Data on the first experience of insulin degludec (Tresiba®) treatment for type 2 diabetes in daily clinical practice

Data on the first experience of insulin degludec (Tresiba®) treatment for type 2 diabetes in daily clinical practice

Aim: The aim of this study was to evaluate the efficacy and safety of the new ultra-long-acting insulin degludec (Tresiba®) in the treatment of type 2 diabetes in routine clinical practice.Methods: This primary health care clinical observational study included 20 insulin-naïve type 2 diabetic patien...

Full description

Saved in:
Bibliographic Details
Main Authors: Lyudmila Alexandrovna Suplotova, Nikolay Valer'evich Plotnikov, Natal'ya Valer'yanovna Romanova, Larisa Nikolaevna Bel’chikova, Ekaterina Viktorovna Khieva, Marina Vladimirovna Shestakova
Format: article
Language:EN
RU
Published: Endocrinology Research Centre 2015
Subjects:
type 2 diabetes mellitus
insulin degludec
glycaemic control
hypoglycaemia
quality of life
Nutritional diseases. Deficiency diseases
RC620-627
Online Access:https://doaj.org/article/bb9f11fa3266492f955d458c1ee4ebc2
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doaj.org/article/bb9f11fa3266492f955d458c1ee4ebc2

Similar Items